Cita APA

Kim Anh, M., Kasymjanova, G., Cohen, V., & Agulnik, J. (2016). Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? Curr Oncol.

Citación estilo Chicago

Kim Anh, Ma, Goulnar Kasymjanova, Victor Cohen, y Jason Agulnik. "Response To: Second-line Treatment of Non-small-cell Lung Cancer With Wild-type EGFR Status. What Is the Best Approach?" Curr Oncol 2016.

Cita MLA

Kim Anh, Ma, Goulnar Kasymjanova, Victor Cohen, y Jason Agulnik. "Response To: Second-line Treatment of Non-small-cell Lung Cancer With Wild-type EGFR Status. What Is the Best Approach?" Curr Oncol 2016.